Perspectivas 2026 de Pumtech Korea (251970). Análisis cualitativo profundo de su negocio de bombas cosméticas, dispensadores airless y envases, el auge exportador de las marcas indie de K-beauty, el know-how de dispensado como foso y los riesgos reales de concentración de clientes y ciclos de moda.
Pumtech Korea (251970) 2026 stock outlook. A qualitative deep dive into its cosmetic pump, airless dispenser and packaging business, the K-beauty indie-brand export boom, dispensing know-how as a moat, and the real risks of customer concentration and beauty fashion cycles.
Análisis de Tonymoly (KRX 214420) 2026: el colapso del modelo de tienda monomarca, la reconstrucción vía Amazon y Costco en EE. UU. más Japón y el Sudeste Asiático, la diversificación en ODM y la filial de probióticos A2Gen, los vientos de cola exportadores del K-beauty y el riesgo de envejecimiento de marca.
Tonymoly (KRX 214420) 2026 stock analysis: the collapse of the single-brand road-shop model, the rebuild through Amazon and Costco in the US plus Japan and Southeast Asia, ODM and A2Gen probiotics diversification, K-beauty export tailwinds, and brand-aging turnaround risk.
Perspectivas 2026 de I Family SC (KOSDAQ 114840). Análisis cualitativo a fondo de la marca de cosmética de color rom&nd, su posición de primer nivel en Japón, la expansión por el Sudeste Asiático y EE. UU., el modelo indie ODM de bajos activos, los canales Olive Young y de compra transfronteriza, y los riesgos de concentración en una sola marca y del ciclo de moda K-beauty.
I Family SC (KOSDAQ 114840) 2026 stock outlook. A deep, qualitative look at the rom&nd color cosmetics brand, its top-tier position in Japan, expansion across Southeast Asia and the US, the asset-light indie ODM model, Olive Young and cross-border channels, and the single-brand concentration and K-beauty trend-cycle risks.
Perspectiva 2026 de la acción de Able CnC (KOSDAQ 078520). Análisis del relanzamiento de las marcas MISSHA y A'PIEU, el giro de las tiendas monomarca hacia Olive Young, el canal online y la exportación a Japón, el declive estructural del formato road shop, el peso del fondo IMM PE y la volatilidad de márgenes, comparado con Clio y Tonymoly.
Able CnC (KOSDAQ 078520) 2026 stock outlook. A deep look at the MISSHA and A'PIEU brand rebrand, the shift from single-brand road shops to Olive Young health-and-beauty, online and Japan exports, structural road-shop decline, the IMM PE ownership overhang, valuation and margin volatility, benchmarked against Clio and Tonymoly.
Perspectivas 2026 de Manyo Factory (KOSDAQ 439090). Análisis cualitativo de su marca de belleza limpia y vegana y su producto estrella Pure Cleansing Oil, los canales de exportación a Japón, EE. UU. y el Sudeste Asiático, el modelo ODM de activos ligeros, la dependencia de distribuidores como Silicon2 y los riesgos de gasto en marketing y tendencias para el inversor global.
Manyo Factory (KOSDAQ 439090) 2026 stock outlook. A qualitative deep dive into its vegan clean-beauty brand equity and Pure Cleansing Oil hero product, Japan, US and Southeast Asia export channels, asset-light ODM model, reliance on distributors like Silicon2, and marketing-spend and beauty-trend risks for global investors.
Perspectivas 2026 de Amorepacific Group (KOSPI 002790) para el inversor extranjero. Diferencia entre la holding y la operadora 090430, el desapalancamiento en China y duty-free, el reequilibrio hacia EE.UU. y Japon, la compra de Cosrx, el valor de marca de Sulwhasoo y Laneige, y el descuento NAV.
Amorepacific Group (KOSPI 002790) 2026 outlook for foreign investors. How the holding company differs from operating co 090430, the China and duty-free deleveraging, the US and Japan rebalancing, the Cosrx acquisition, Sulwhasoo and Laneige brand equity, and the NAV discount debate.
Análisis de VT Cosmetics (KOSDAQ 018290) 2026: fuerza de marca de Reedle Shot, crecimiento explosivo de exportaciones indie-beauty a Japón y Amazon, canal Olive Young, dependencia de un solo producto estrella, riesgo de tendencias y el negocio de entretenimiento, desde la óptica del inversor global.
VT Cosmetics (KOSDAQ 018290) 2026 stock analysis: Reedle Shot brand strength, explosive Japan and Amazon indie-beauty export growth, Olive Young channel, single-hit-product dependence, cosmetics trend risk, and the entertainment segment — from a global investor's view.
Aekyung Industrial (KOSPI: 018250) 2026 stock analysis for global investors: the AGE 20's cosmetics franchise reducing its China export dependence and rebranding, the Kerasys, 2080, and Trio household-goods cash cow, domestic consumption, raw-material and currency exposure, LINE Friends and IP collaborations, the beauty-segment rebound scenario, and Aekyung Group risk.
Cosmecca Korea (KOSDAQ: 241710) 2026 stock analysis: the cosmetics ODM/OEM manufacturing engine behind the K-beauty and indie-brand export boom, the strategic value of US subsidiary Englewood Lab and its onshore American production, the split US-China-Korea manufacturing base, customer diversification, and the input-cost, FX, and tariff variables that drive margins — analyzed qualitatively for global investors.
CLIO (KOSDAQ 237880) 2026 stock analysis: Peripera, Goodal, and CLIO brand portfolio, Olive Young H&B channel plus online and global (Japan, US Amazon) expansion, indie-brand competition, cost and marketing structure, and channel-dependence, China-exposure, and trend-sensitivity risks.
APR Corp (KRX 278470) 2026 stock outlook. A qualitative deep dive into its beauty-tech model that fuses home beauty devices (Medicube AGE-R) with skincare brands, the razor-and-blade device-plus-consumables revenue engine, high-growth global expansion via Amazon and direct-to-consumer in the US and Japan, marketing-spend and trend-dependency risks, and the valuation compression danger baked into a growth premium.
Silicon2 (KRX 257720) 2026 stock outlook for global investors. A qualitative deep dive into the StyleKorean reverse-cross-border platform and the global K-beauty export boom: indie-brand distribution across the US, Middle East, and Europe, logistics infrastructure, brand and fad concentration risk, high-growth high-valuation volatility, currency tailwinds, and how it compares with cosmetics and distribution peers.
Cosmax (KRX: 192820) 2026 stock analysis: the world-leading cosmetics ODM's formulation and R&D moat, the K-beauty indie brand trickle-down effect, production hubs in China, the US, Indonesia, and Thailand, China risk, cost and FX pressure, a Kolmar Korea comparison, and how global investors should frame this picks-and-shovels cosmetics play.
Perspectivas 2026 de la acción Kolmar Korea (KRX 161890). Análisis cualitativo del ODM/OEM de cosméticos número uno de Corea, su exposición directa al boom exportador de las marcas indie de K-beauty, sus plantas en EE. UU. y China, su negocio farmacéutico CMO y su filial HK inno.N (K-CAB). También cubrimos los riesgos de ciclo de consumo, dependencia de marcas clientes, China y divisa para el inversor internacional.
Kolmar Korea (KRX 161890) 2026 stock outlook. A qualitative analysis of Korea's No.1 cosmetics ODM/OEM, its direct leverage to the indie K-beauty export boom, US and China manufacturing bases, pharma CMO operations, and its HK inno.N (K-CAB) subsidiary engine. We also cover demand-cycle, customer-brand dependence, China, and FX risks for global investors.
Análisis de LG Household & Health Care (051900) 2026: tres divisiones — Belleza (cosmética de lujo The History of Whoo), Hogar y Cuidado Diario, y la embotelladora de Coca-Cola Korea. Recuperación de la demanda china, normalización del duty-free/daigou, reseteo de la marca Whoo, dividendo y por qué este compounder rerratado amortigua la ciclicidad cosmética con flujo de caja estable de bebidas.
LG Household & Health Care (051900) 2026 stock analysis: three divisions — Beauty (The History of Whoo luxury cosmetics), Home & Daily Beauty, and Coca-Cola Korea bottling. China demand recovery, duty-free/daigou normalization, Whoo brand reset, dividend, and why this de-rated compounder cushions cosmetics cyclicality with stable beverage cash flow.